Development of Monoclonal Antibody-Based EIA for Tetranor-PGDM which Reflects PGD(2) Production in the Body

Tetranor-PGDM is a metabolite of PGD(2). Urinary tetranor-PGDM levels were reported to be increased in some diseases, including food allergy, Duchenne muscular dystrophy, and aspirin-intolerant asthma. In this study, we developed a monoclonal antibody (MAb) and a competitive enzyme immunoassay (EIA)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: Nagata, Nanae, Masuko, Sakura, Inoue, Rikako, Nakamura, Tatsuro, Aritake, Kosuke, Murata, Takahisa
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8096570/
https://ncbi.nlm.nih.gov/pubmed/33997056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5591115
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars